CDbio

CDbio

MCD
$0.349749139%-5.61

Key Metrics

Price$0.349749139
Real Volume (24H)$687.83
MarketcapN/A
Fully Diluted Valuation$100,000,000
ATH$4.13
ATH Date12/25/2022, 8:37:03 AM
ATL$1.89
ATL Date9/26/2022, 3:52:31 PM
Circulating SupplyN/A
Total Supply1B
WebsiteN/A
WhitepaperN/A
Popularity Rank7442
Chart
What is CDbio?

CDBIO Foundation is a medical organization that offers advanced molecular medical and healthcare services in Seychelles. Its services are based on cutting-edge molecular physics, a field that studies the physical and chemical properties of molecules, atoms, and their interactions. CDBIO's mission is to provide personalized and optimized medical services to individual patients by using molecular sensors to diagnose diseases and monitor health conditions according to medication effects.

The foundation's work is led by Yasama Yasuhiko, CEO of Idea International, who is also a CTO of CDBIO. Yasama is a renowned research co-worker and molecular physics expert, currently working at the Tohoku University Research and Analytical Center for Giant Molecular Studies. He has developed molecular sensors using lithium-resistant fullerene, which are highly precise technologies that allow one electron to flow per molecule. These sensors can diagnose diseases and monitor health conditions, enabling customized prescriptions and treatments optimized for patient characteristics.

CDBIO's Molecular Medical & Healthcare Platform is based on this advanced technology, combining the expertise of global molecular physics and electrochemical scholars with the collective intelligence of professional medical communities and patient communities. The foundation aims to create the world's only blockchain healthcare ecosystem that provides early diagnosis of all diseases and personalized medical services to individual patients. This molecular-medical/healthcare platform will help overcome diseases and further contribute to human health and prolongation through disease prevention and systematic healthcare.

CDBIO's goal is to create a healthcare ecosystem that is accessible, personalized, and optimized for individual patients. By using molecular sensors, the foundation can diagnose diseases at an early stage and provide customized treatments that are optimized for the patient's unique characteristics. This approach ensures that patients receive the best possible care, leading to better health outcomes.

In conclusion, CDBIO Foundation is a medical organization that provides advanced molecular medical and healthcare services in Seychelles. Its mission is to create a healthcare ecosystem that combines the expertise of global molecular physics and electrochemical scholars with the collective intelligence of professional medical communities and patient communities. By using molecular sensors and blockchain technology, CDBIO aims to provide personalized and optimized medical services to individual patients and contribute to human health and prolongation through disease prevention and systematic healthcare.

Disclaimer

The investment information, comments, and recommendations provided here do not fall under the scope of investment consulting. Therefore, making an investment decision based solely on the information and comments provided here may not yield results that meet your expectations.

Stay ahead of the competition by accessing high-quality data, advanced tools, and expert research.

Try for Free

Top Assets

AssetPrice24HMcap
Loading...

We use cookies for personalization, social media, and analytics, and share usage data with partners.